DNA Sequencing. Fluorescence-based DNA sequencing will be provided by the Genome Sciences - Genomic Resource Center (GS-GRC). They routinely resequence samples from investigator-supplied samples in candidate genes or specified DNA regions. These are processed in sets of 96 (94 + 2 controls) (The minimum sample set size is 48 (47 + 1 control)). For this project, (number) samples will be submitted to GS-GSC. We provide information on custom resequencing, by providing the genome coordinates to define the targets to be sequenced. The only regions that will be excluded are those refractory to PCR amplification or sequencing (e.g., low-complexity repeats). (Include information about your defined genes or regions here) Once the region has been defined the GS-GCR team amplifies the specified gene(s) or region(s) requested by PCR. The PCR primers are designed to specifically target the gene(s) or region(s) requested. They are Tm matched and designed from a masked reference sequence to exclude design in problematic regions such as repeat motifs and high GC content. Each primer pair is "tailed" with a universal M13 forward and reverse sequencing primer to enable subsequent sequencing. Optimal PCR conditions are determined empirically or computationally and confirmed by multiple quality assurance steps. Once the regions are amplified, each PCR product is sequenced from the forward and reverse direction to provide double-stranded coverage. Sequencing is carried out with Sanger Big-Dye Terminator sequencing, and detection with capillary-based sequencing machines (ABI 3730XL). Difficult sequences/regions or failed PCR are handled as follows: 1) Attempting alternative PCR chemistries and thermocycling parameters for the failed region; and 2) if a region fails two attempts with alternative conditions, that region is considered refractory to analysis. In general, less than 10 to 15 percent of targeted regions are refractory in this manner. To identify sequence variants, the sequencing traces are base-called and assembled on the reference sequence, and then a computational tool (i.e., PolyPhred) is applied to resolve mixed (heterozygous) sequences in the trace (the signature of a SNP/variant). The SNPs/variants are identified by confirmation on both the forward and reverse strands and, if required, with manual review by specialized data analysts. The only DNA variations that we report are SNPs or small (less than 20 bp) insertion/deletion polymorphisms. The GS-GRC produces sequence data and variant calls of the extremely high quality, and it well-documented error rate less than 0.5%. The center will provide a defined set of output data that includes the sequence files in FASTA format for the regions sequenced, the genotype and frequency of each allele for each SNP/variant and insertion-deletion polymorphism detected according to position mapping in the human genome, mapping of these SNPs/variants in the context of gene structure, and if requested, input files for programs like PHASEII, Haploview and PLINK. These data files are provided via a password-protected project web site. They also include the data analysis and quality assurance steps necessary to identify variants directly from the sequence traces, alleviating the need for the applicant to perform these tasks. However, if requested, we do provide copies of the Consed-compatible trace files at the completion of the study through FTP access or disk copy.